ArticleJournal of immunology research2022

Thyroid Dysfunction as a Predictive Indicator in Camrelizumab of Advanced Esophageal Squamous Cell Carcinoma.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.